Skip to content
akaturk Academic measurement

OpenAlex topic

Drug-Induced Adverse Reactions

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 2,335 works 59 author topics

Works

2,335 works

  1. Internet Search Behavior for Urticaria: A Google Trends Analysis in Türkiye: Descriptive Research 2026

    Amaç: Google tarafından sunulan Google Trends, sağlıkla ilgili arama davranışlarını analiz etmeye olanak tanıyan bir araçtır. Bu çalışmanın amacı, Google kullanıcılarının ürtiker ile ilgili arama davranışlarını incelemek ve bu davranışlar ile Türkiye'de illere göre kişi başına düşen gayrisafi milli hasıla (GSMH) ve eğ…

  2. PECU: A multicenter study on pediatric patients with cold-induced urticaria 2026

    BACKGROUND: Cold-induced urticaria (ColdU) is a rare chronic inducible urticaria that can cause systemic reactions, including cold-induced anaphylaxis (ColdA), but pediatric data are limited. The aim of this study was to evaluate the clinical characteristics, comorbidities, management approaches, risk of anaphylaxis,…

  3. Specialist teaching to school pupils can increase knowledge and confidence surrounding anaphylaxis 2026

    For transparency, the peer review documents associated with this article are available at https://doi.org/10.1111/pai.70330. The data that support the findings of this study are available from the corresponding author upon reasonable request. Appendix S1. Table S1. Table S2. Table S3. Please note: The publisher is not…

  4. Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization Protocols 2026

    No abstract yet.

  5. ESCMID clinical guidelines on the evaluation and management of a reported antibiotic allergy 2026

    SCOPE: Antibiotic allergies remain one of the most frequently documented drug allergies in clinical records. It is well established that only a small proportion-estimated at 5% to 10%-represents true immune-mediated hypersensitivity. Mislabelling can contribute to the development of antimicrobial resistance via prescr…

  6. Levofloxacin-induced dyskinesia in an elderly patient with granulomatosis with polyangiitis 2026

    No abstract yet.

  7. Internet Search Behavior for Urticaria: A Google Trends Analysis in Türkiye: Descriptive Research 2026

    Amaç: Google tarafından sunulan Google Trends, sağlıkla ilgili arama davranışlarını analiz etmeye olanak tanıyan bir araçtır. Bu çalışmanın amacı, Google kullanıcılarının ürtiker ile ilgili arama davranışlarını incelemek ve bu davranışlar ile Türkiye'de illere göre kişi başına düşen gayrisafi milli hasıla (GSMH) ve eğ…

  8. Azathioprine-induced hypersensitivity pneumonitis in an autoimmune hepatitis patient: A rare case report 2026

    year of continuous therapy. We discuss the potential immunopathogenic mechanisms, review the limited literature on AZA-related pulmonary toxicity, and emphasize the importance of early recognition to prevent irreversible lung injury and optimize patient outcomes.

  9. Successful oral levothyroxine desensitization in a 13‐year‐old child with severe hypothyroidism after radiotherapy: A case report 2026

    The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/pai.70333.

  10. Psychological Symptom Burden after Anaphylaxis in Adults: A Cross-Sectional Study 2026

    INTRODUCTION: Anaphylaxis is an acute, potentially life-threatening systemic hypersensitivity reaction. Psychological symptoms, including anxiety, depressive symptoms, and post-traumatic stress symptoms (PTSS), may persist after the acute episode; however, adult data remain limited. This study aimed to describe the pr…

  11. Real-World Outcomes of Rapid Drug Desensitization for Taxane and Platinum Chemotherapy 2026

    INTRODUCTION: Hypersensitivity reactions (HSRs) to taxane- and platinum-based chemotherapeutic agents are common and may interrupt essential cancer therapy. Rapid drug desensitization (RDD) enables patients to continue treatment safely; however, detailed analyses directly comparing desensitization outcomes between tax…

  12. Early Post-Marketing Safety Signals of Anifrolumab in EudraVigilance: A Belimumab-Comparator Disproportionality Analysis 2026

    Background: Anifrolumab is a type I interferon receptor antagonist approved for adults with moderate-to-severe systemic lupus erythematosus (SLE). Although clinical trials established its efficacy and expected safety profile, post-marketing analyses using public EudraVigilance data remain limited. Spontaneous-report p…

Academicians

59 academicians